646
Views
76
CrossRef citations to date
0
Altmetric
Reviews

Micronutrients and the Premenstrual Syndrome: The Case for Calcium

, MD
Pages 220-227 | Received 01 Nov 1999, Accepted 01 Dec 1999, Published online: 14 Jun 2013

REFERENCES

  • Frank RT: The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26: 1053–57, 1931.
  • Reid RL, Yen SSC: Premenstrual syndrome. Am J Obstet Gynecol 139: 85–104, 1981.
  • Bruce J, Russel G: Premenstrual tension. A study of weight changes and balances of water sodium and potassium. Lancet 2: 267–271, 1962.
  • Aedo AR, Langren BM, Cekan Z, Diczfalusy E: Studies on the pattern of circulating steroids in the normal menstrual cycle. Acta Endocrinol (Copenh) 82: 600–616, 1976.
  • Urban RJ, Veldhuis JD, Dufau ML: Estrogen regulates the GnRH-stimulated secretion of biologically active LH. J Clin Endocrinol Metab 72: 660–668, 1991.
  • Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Andersen R, Merriam GR: Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 158: 5–11, 1988.
  • Facchinetti F, Genazzani AD, Martignoni E, Fioroni L, Sances G, Genazzani AR: Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. Psychoneuroendocrinology 15: 269–277, 1990.
  • Cerin A, Collins A, Landgren BM, Eneroth P: Hormonal and biochemical profiles of premenstrual syndrome. Acta Obstet Gynecol Scand 72: 337–343, 1993.
  • Andersch B, Abrahamsson L, Wenderstem C, Ohman R, Hahn L: Hormone profiles in premenstrual tension: effects of bromocriptine and diuretics. Clin Endocrinol 11: 657–64, 1979.
  • Mortola JF, Girton L, Yen S: Depressive episodes in premenstrual syndrome. Am J Obstet Gynecol 161: 1682–7, 1989.
  • Andersch B: Bromocriptine and premenstrual symptoms: a survey of double blind trials. Obstet Gynecol Sur 38: 643–6, 1983.
  • Ferrin M, Jewelewicz R, Warren M: The premenstrual syndrome. In “The Menstrual Cycle.” Oxford University Press pp 198–204, 1993.
  • Mortola JF, Girton L, Fischer U: Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 71: 252A–252F, 1991.
  • Casson P, Hahn PM, Van Vugt DA, Reid RL: Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 162: 99–105, 1990.
  • Muse KN, Cetel NS, Futterman LA, Yen SSC: The premenstrual syndrome: effects of medical ovariectomy. N Engl J Med 311: 1345–1349, 1984.
  • Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR: Differential behavioral effects of gonadal steroids in women with and without premenstrual syndrome. N Engl J Med 338: 209–216, 1998.
  • Cressent M, Elie C, Taboulet J, Moukhtar S, Milhaud: Calcium regulating hormones during the estrous cycle of the rat. Proc Soc Exp Biol Med 172: 158–162, 1983.
  • Piffaretti JM: Etude des variations des taux plasmatiques du phosphore inorganique, du calcium et du magnesium au cours du rythme nycthemeral et menstruel chez la femme normale. Schweiz Rundsch Med Prax 61: 670–677, 1972.
  • Sato N, Henkin RI: Pituitary-gonadal regulation of copper and zinc metabolism in the female rat. Am J Physiol 225: 508–512, 1973.
  • Kenny A: Vitamin D metabolism: physiological regulation in egg-laying Japanese quail. Am J Physiol 230: 1609–1615, 1976.
  • Tanaka Y, Castillo L, Deluca HF: Control of renal vitamin D hydroxylases in birds by sex hormones. Proc Natl Acad Sci 73: 2701–2705, 1976.
  • Brommage R, Binacua C, Carrie AL: Ovulation-associated increase in intestinal calcium absorption during the rat estrous cycle is blunted by ovariectomy. Biol Reprod 49: 544–548, 1993.
  • Pitkin R, Reynolds WA, Williams GA, Hargis GK: Calcium regulating hormones during the menstrual cycle. J Clin Endocrinol Metab 47: 626–632, 1978.
  • Gray TK, McAdoo T, Hatley L, Lester GE, Thierry M: Fluctuation of serum concentration of 1,25 dihydroxyvitamin D during the menstrual cycle. Am J Obstet Gynecol 144: 880–884, 1982.
  • Tjellesen L, Christiansen C, Hummer L, Larsen NE: Unchanged biochemical indices of bone turnover despite fluctuations in 1,25 dihydroxyvitamin D during the menstrual cycle. Acta Endocrinologica 102: 476, 1983.
  • Das K, Chowdhury AR: Metallic ions during menstrual cycle in normally menstruating women. Indian J Med Sci 51: 52–4, 1997.
  • Muneyyirci-Delale O, Nacharaju V, Dalloul M, Altura B, Altura BT: Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium. Fertil Steril 71: 869–872, 1999.
  • London RS, Murphy L, Kitlowski KE, Reynolds MA: Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 32: 400–404, 1987.
  • Wyatt KM, Dimmock PW, Jones PW, Shaugn O’Brien PM: Efficacy of vitamin B6 in the treatment of premenstrual syndrome: systematic review. BMJ 318: 1375–1381, 1999.
  • Collins A, Cerin A, Coleman G, Landgren BM: Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 81: 93–98, 1993.
  • Khoo SK, Munro C, Battistutta D: Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 153: 189–192, 1990.
  • Reeves BD, Garvin JE, McElin TW: Premenstrual tension: Symptoms and weight changes related to potassium therapy. Am J Obstet Gyn 109: 1036–1041, 1971.
  • Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RE, Genazzani AR: Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 78: 177–181, 1991.
  • Walker AF, De Souza M, Vickers MF: Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Women’s Health 7: 1157–1165, 1998.
  • Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J: Calcium supplementation in premenstrual syndrome. J Gen Intern Med 4: 183–189, 1989.
  • Penland JG, Johnson PE: Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 168: 1417–1423, 1993.
  • Thys-Jacobs S, Starkey P, Bernstein D, Tian J: Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 179: 444–52, 1998.
  • Lee SJ, Kanis JA: An association between osteoporosis and premenstrual and postmenstrual symptoms. Bone and Mineral 24: 127–134, 1994.
  • Thys-Jacobs S, Silverton M, Alvir J, Paddison P, Rico M, Goldsmith S: Reduced bone mass in women with premenstrual syndrome. J Women’s Health 4: 161–168, 1995.
  • Thys-Jacobs S, Alvir MAJ: Calcium regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab 80: 2227–2232, 1995.
  • Weston PG, Howard MQ: The determination of sodium, potassium, calcium and magnesium in the blood and spinal fluid of patients suffering from manic depressive insanity. Arch Neurol Psychiat 8: 179–183, 1922.
  • Carman JS, Crews E, Bancroft A, et al.: Calcium and calcium regulating hormones in the biphasic periodic psychoses. J Operational Psychiat 11: 5–17, 1980.
  • Jimerson DC, Post R, Carman JS, van Kammen DP, Wood JH, Goodwin FK: CSF calcium: clinical correlates in affective illness and schizophrenia. Biol Psychiat 14: 37–51, 1979.
  • Borer M, Bhanot V: Hyperparathyroidism: neuropsychiatric manifestations. Psychosomatics 26: 597–601, 1985.
  • Joborn C, Hetta J, Palmer M, Akerstrom G, Ljunghall S: Psychiatric symptomatology in patients with primary hyperparathyroidism. Upsala J Med 91: 77–87, 1986.
  • Joborn C, Hetta J, Johsnsson H, Rasstad J, Agren H, Akerstrom G, Ljunghall S: Psychiatric morbidity in primary hyperparathyroidism. World J Surg 12: 476–481, 1988.
  • Joborn C, Hetta J, Rastad J, Agren H, Akerstrom, Ljunghall S: Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry 23: 149–158, 1988.
  • Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskanman Bendz L: CSF monoamines metabolites in melancholia. Acta Psychiatr Scand 69: 201–205, 1984.
  • Traskman L, Asberg M, Bertilsson L, Sjostrand L: Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38: 631–639, 1981.
  • Rapkin AJ: The role of serotonin in premenstrual syndrome. Clin Obstet Gynecol 35: 629–636, 1922.
  • Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D: Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 332: 1529–34, 1995.
  • Gallagher JC, Riggs BL, Deluca HF: Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51: 1359–1364, 1980.
  • Young MN, Nordin BEC: Effect of natural and artificial menopause on plasma and urinary calcium and phosphorus. Lancet 2: 118, 1967.
  • Heaney RP: Estrogens and postmenopausal osteoporosis. Clin Obstet Gyecol 19: 791, 1976.
  • Stice SL, Ford SP, Rosazza JP, Van-Orden DE: Role of 4-hydroxylated estradiol in reducing Ca2+ uptake of uterine arterial smooth muscle cells through potential sensitive channels. Biol Reprod 36: 361–368, 1987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.